MGRN1 and Miyoshi myopathy: Other limitations are the lack of a retrospective validation study with actual surgical specimens from MM patients, and the fact that transcriptomic analysis of MGRN1-KO cells was performed using a triple WT cell line, i.e., belonging to one out of four molecular subtypes.